Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial
JSJoël ShapiroJJJ. Jan B. van LanschotMCMaarten C.C.M. HulshofPVPieter van HagenMIMark I. van Berge Henegouwen
Erasmus University Rotterdam · Erasmus MC · +10 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
2,534
total citations
- FWCI
- 148.06
- Percentile
- 100%
- References
- 25
Citations per year
Authors
30- JSJoël ShapiroCorresponding
Erasmus University Rotterdam, Erasmus MC
- JJJ. Jan B. van Lanschot
Erasmus University Rotterdam, Erasmus MC, Academic Medical Center
- MCMaarten C.C.M. Hulshof
Academic Medical Center
- PVPieter van Hagen
Erasmus MC, Erasmus University Rotterdam
- MIMark I. van Berge Henegouwen
Academic Medical Center
Topics & keywords
Topics
Keywords
- Medicine
- Chemoradiotherapy
- Carboplatin
- Surgery
- Clinical endpoint
- Radiation therapy
- Cancer
- Adenocarcinoma
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.